Yeah the announcement specifies the data is from the DREAMHF trial, I was responding to whytees statement.
I'm guessing this data hasn't been presented previously because the measurement of LVEF on all the patients at 12 months took a while to analyse?
Again, it would be nice if they presented the data, as the way they've explained the effect is convoluted, but it's looking promising!
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE, page-109
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |